Jerry Teitel

567 total citations
20 papers, 341 citations indexed

About

Jerry Teitel is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Jerry Teitel has authored 20 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 6 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in Jerry Teitel's work include Hemophilia Treatment and Research (17 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers) and Platelet Disorders and Treatments (7 papers). Jerry Teitel is often cited by papers focused on Hemophilia Treatment and Research (17 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers) and Platelet Disorders and Treatments (7 papers). Jerry Teitel collaborates with scholars based in Canada, United Kingdom and United States. Jerry Teitel's co-authors include David Lillicrap, Man‐Chiu Poon, J. Sek, Sara J. Israels, Dorothy Barnard, Georges‐Étienne Rivard, Manuel Carção, C. R. M. Hay, Elena Santagostino and Jay N. Lozier and has published in prestigious journals such as BMJ Open, Thrombosis Research and American Journal of Medical Genetics.

In The Last Decade

Jerry Teitel

19 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerry Teitel Canada 8 319 93 34 21 8 20 341
Chiara Biasoli Italy 10 356 1.1× 89 1.0× 57 1.7× 26 1.2× 19 2.4× 26 386
Patrick F. Fogarty United States 8 193 0.6× 54 0.6× 13 0.4× 13 0.6× 3 0.4× 18 225
G. Auerswald Germany 10 376 1.2× 121 1.3× 35 1.0× 7 0.3× 31 3.9× 14 397
Amy Shapiro United States 5 483 1.5× 122 1.3× 65 1.9× 14 0.7× 10 1.3× 5 517
Anne Rafowicz France 7 217 0.7× 38 0.4× 52 1.5× 10 0.5× 11 1.4× 11 230
G Rivolta Italy 4 242 0.8× 58 0.6× 40 1.2× 7 0.3× 4 0.5× 6 257
R. Parra Spain 12 273 0.9× 61 0.7× 43 1.3× 31 1.5× 7 0.9× 21 299
Avrita Campinha‐Bacote United States 5 319 1.0× 101 1.1× 17 0.5× 15 0.7× 8 344
Alex Allepuz Switzerland 6 100 0.3× 72 0.8× 12 0.4× 19 0.9× 7 0.9× 15 134
Ivan Krečak Croatia 7 78 0.2× 132 1.4× 69 2.0× 18 0.9× 3 0.4× 55 185

Countries citing papers authored by Jerry Teitel

Since Specialization
Citations

This map shows the geographic impact of Jerry Teitel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry Teitel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry Teitel more than expected).

Fields of papers citing papers by Jerry Teitel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerry Teitel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry Teitel. The network helps show where Jerry Teitel may publish in the future.

Co-authorship network of co-authors of Jerry Teitel

This figure shows the co-authorship network connecting the top 25 collaborators of Jerry Teitel. A scholar is included among the top collaborators of Jerry Teitel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerry Teitel. Jerry Teitel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pavenski, Katerina, et al.. (2024). Cross-reacting antiporcine factor VIII inhibitors in patients with acquired hemophilia A. Research and Practice in Thrombosis and Haemostasis. 8(6). 102553–102553.
2.
Sussman, Marshall S., et al.. (2023). T2 mapping magnetic resonance imaging of cartilage in hemophilia. Research and Practice in Thrombosis and Haemostasis. 7(6). 102182–102182. 2 indexed citations
3.
St‐Louis, Jean, Pratima Chowdary, G. Dolan, et al.. (2022). Multidisciplinary Team Care of Patients with Hemophilic Arthropathy: A Qualitative Assessment of Contemporary Practice in the UK and Canada. Clinical and Applied Thrombosis/Hemostasis. 28. 2975251506–2975251506. 6 indexed citations
4.
Liederman, Zachary, et al.. (2020). Hemorrhagic, thrombotic and obstetric complications of congenital dysfibrinogenemia in a previously asymptomatic woman. Thrombosis Research. 196. 127–129. 5 indexed citations
5.
Tang, Grace H., Erin H. Norris, Jessica Petrucci, et al.. (2019). Bone health in symptomatic carriers of haemophilia A: a protocol for a multicentre prospective matched-cohort study. BMJ Open. 9(12). e032891–e032891. 3 indexed citations
6.
Rivard, Georges‐Étienne, Manuel Carção, Jerry Teitel, et al.. (2016). Pilot study of once‐a‐day prophylaxis for youth and young adults with severe haemophilia A. Haemophilia. 22(5). e401–5. 6 indexed citations
7.
Vézina, Catherine, Manuel Carção, Claire Infante‐Rivard, et al.. (2014). Incidence and risk factors for inhibitor development in previously untreated severe haemophilia A patients born between 2005 and 2010. Haemophilia. 20(6). 771–776. 26 indexed citations
8.
Matino, Davide, Jerry Teitel, David Page, et al.. (2014). The haemophilia certification system in Canada.. PubMed. 12 Suppl 3. e531–41. 3 indexed citations
9.
Chan, Anthony K.C., Kathryn E. Webert, Nancy M. Heddle, et al.. (2014). First analysis of 10‐year trends in national factor concentrates usage in haemophilia: data from CHARMS, the Canadian Hemophilia Assessment and Resource Management System. Haemophilia. 20(4). e251–9. 6 indexed citations
10.
Webert, Kathryn E., Georges‐Étienne Rivard, Jerry Teitel, et al.. (2011). Low prevalence of inhibitor antibodies in the Canadian haemophilia population. Haemophilia. 18(3). e254–9. 8 indexed citations
11.
Teitel, Jerry, Erik Berntorp, G. Dolan, et al.. (2011). A consensus statement on clinical trials of bypassing agent prophylaxis in inhibitor patients. Haemophilia. 17(3). 516–521. 7 indexed citations
12.
Teitel, Jerry, Manuel Carção, David Lillicrap, et al.. (2008). Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care. Haemophilia. 15(1). 227–239. 44 indexed citations
13.
Teitel, Jerry, Erik Berntorp, Peter W. Collins, et al.. (2007). A systematic approach to controlling problem bleeds in patients with severe congenital haemophilia A and high‐titre inhibitors. Haemophilia. 13(3). 256–263. 62 indexed citations
14.
Teitel, Jerry & Irwin Walker. (2007). CANADIAN COMPREHENSIVE CARE STANDARDS FOR HEMOPHILIA AND OTHER INHERITED BLEEDING DISORDERS. 2 indexed citations
15.
Teitel, Jerry, Dorothy Barnard, Sara J. Israels, et al.. (2004). Home management of haemophilia. Haemophilia. 10(2). 118–133. 92 indexed citations
16.
Kessler, C. M., et al.. (1998). Safety of coagulation factor concentrates. Haemophilia. 4(4). 393–401. 10 indexed citations
17.
Kessler, Craig M., et al.. (1998). National haemophilia treatment protocols: Canada. Haemophilia. 4(4). 422–423. 5 indexed citations
18.
Lozier, Jay N., Elena Santagostino, Carol K. Kasper, Jerry Teitel, & C. R. M. Hay. (1993). Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors.. PubMed. 30(2 Suppl 1). 10–21. 44 indexed citations
19.
Percy, M. E., Marie Garvey, John Freedman, et al.. (1988). Carrier detection in hemophilia A: ABO blood group, multiple measurements, and application of logistic discrimination. American Journal of Medical Genetics. 31(4). 871–879. 2 indexed citations
20.
Phillips, Mark, David Lillicrap, Alan R. Giles, et al.. (1987). Carrier detection of haemophilia A using DNA markers in families with an isolated affected male. Clinical Genetics. 32(1). 10–19. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiara Biasoli Breakdown of academic impact, for papers by Patrick F. Fogarty Breakdown of academic impact, for papers by G. Auerswald Breakdown of academic impact, for papers by Amy Shapiro Breakdown of academic impact, for papers by Anne Rafowicz Breakdown of academic impact, for papers by G Rivolta Breakdown of academic impact, for papers by R. Parra Breakdown of academic impact, for papers by Avrita Campinha‐Bacote Breakdown of academic impact, for papers by Alex Allepuz Breakdown of academic impact, for papers by Ivan Krečak
Rankless by CCL
2026